WallStSmart
HRTX

Heron Therapeuti

NASDAQ: HRTX · HEALTHCARE · BIOTECHNOLOGY

$0.25
-4.39% today

Updated 2026-11-20

Market cap
$54.09M
P/E ratio
—
P/S ratio
0.37x
EPS (TTM)
$-0.11
Dividend yield
—
52W range
$0 – $2
Volume
5.3M

Heron Therapeuti (HRTX) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$0.25
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—

Financial forecast

Metric20212022202320242025
Revenue$0.1B$0.1B$0.1B$0.1B$0.2B
EPS—————
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -14.50%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.